These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20868273)

  • 21. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells.
    Fang Y; Li G; Ferrie AM
    J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G protein-coupled receptor dimers: functional consequences, disease states and drug targets.
    Dalrymple MB; Pfleger KD; Eidne KA
    Pharmacol Ther; 2008 Jun; 118(3):359-71. PubMed ID: 18486226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact, determination and prediction of drug-receptor residence times for GPCRs.
    Tautermann CS
    Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptorome screening for CNS drug discovery.
    Vortherms TA; Roth BL
    IDrugs; 2005 Jun; 8(6):491-6. PubMed ID: 15906196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 31. New tools for G-protein coupled receptor (GPCR) drug discovery: combination of baculoviral expression system and solid state NMR.
    Ratnala VR
    Biotechnol Lett; 2006 Jun; 28(11):767-78. PubMed ID: 16786240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPCRomics: An Approach to Discover GPCR Drug Targets.
    Insel PA; Sriram K; Gorr MW; Wiley SZ; Michkov A; Salmerón C; Chinn AM
    Trends Pharmacol Sci; 2019 Jun; 40(6):378-387. PubMed ID: 31078319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New paradigms in GPCR drug discovery.
    Jacobson KA
    Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-pharmacology analysis of G protein-coupled receptors.
    Briansó F; Carrascosa MC; Oprea TI; Mestres J
    Curr Top Med Chem; 2011; 11(15):1956-63. PubMed ID: 21851335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nature of efficacy at G protein-coupled receptors.
    Zhao P; Furness SGB
    Biochem Pharmacol; 2019 Dec; 170():113647. PubMed ID: 31585071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology.
    Carrieri A; Pérez-Nueno VI; Lentini G; Ritchie DW
    Curr Top Med Chem; 2013; 13(9):1069-97. PubMed ID: 23651484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G Protein-Coupled Receptor Heteromers.
    Gomes I; Ayoub MA; Fujita W; Jaeger WC; Pfleger KD; Devi LA
    Annu Rev Pharmacol Toxicol; 2016; 56():403-25. PubMed ID: 26514203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of Next-Generation G Protein-Coupled Receptor Drugs: Linking Novel Pharmacology and In Vivo Animal Models.
    Bradley SJ; Tobin AB
    Annu Rev Pharmacol Toxicol; 2016; 56():535-59. PubMed ID: 26738479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.